3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Withdrawn
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Polyps
1
Fatigue
1
Colorectal Neoplasms
1
Colonic Neoplasms
1
Interventions
eicosapentaenoic acid ethyl ester
1
Ofloxacin
1
Fatty Acids, Omega-3
1
Everolimus
1
Doxycycline
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 2
×
Polyps
×
eicosapentaenoic acid ethyl ester
×
Clear all
NCT03661047
2021-11-17
OMICC
Massachusetts General Hospital
Phase 2
Withdrawn